BMY

Bristol-Myers SquibbC

NYSE / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

Peers tracked

U.S. public peers

Grade Position

In line

vs peer average

BMY vs peer average

47/100

BMY vs. peer average (C vs. C)

Grade spread

A 1 · B 2 · C 5 · D 2

Graded peers loaded

Coverage

10 graded

100% of tracked

Peer overview

JNJ is the first available peer comparator.

Large diversified pharma with broad consumer/medtech exposure; defensive revenue mix compared with BMY's oncology focus.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerJNJJohnson Johnson

BMY

Bristol-Myers Squibb

JNJ

Johnson Johnson

Grade

Momentum

Value

Sentiment

Setup Bias

Net Neutral

Market Cap

Posture

Mixed

Open Side-by-Side Comparison Compare all

Grade position vs JNJ

BMY / JNJ

Grade Position

In line

BMY vs. peer average (C vs. C)

47/100

Momentum

BMY

Value

BMY

Sentiment

JNJ

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs BMY

JNJ

60/100

Even

MRK

80/100

-1

PFE

60/100

Even

VRTX

Vertex Pharmaceuticals Inc Common

80/100

-1

SNY

Sanofi SA ADR

60/100

Even

JNJ is the first peer returned for this comparison set.